| Metric | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | $2,537 | $2,810 | $2,791 | $2,974 | $3,047 |
| Gross Profit | $1,325 | $1,550 | $1,531 | $1,647 | $1,703 |
| Operating Income | $423 | $628 | $500 | $506 | $151 |
| Net Income | $335 | $485 | $363 | $356 | $70 |

Edwyn
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | $2,537 | $2,810 | $2,791 | $2,974 | $3,047 |
| Gross Profit | $1,325 | $1,550 | $1,531 | $1,647 | $1,703 |
| Operating Income | $423 | $628 | $500 | $506 | $151 |
| Net Income | $335 | $485 | $363 | $356 | $70 |
Over the five-year period, TELEFLEX INCORPORATED’s revenue showed modest growth, moving from approximately 2.54 billion USD in 2020 to 3.05 billion USD in 2024. The revenue increased by roughly 10% from 2020 to 2021, followed by a slight decline in 2022, and then resumed growth in 2023 and 2024, though at a tapering pace. Gross profit trends largely mirrored revenue movements, with a notable jump of nearly 17% from 2020 to 2021 and steady gains thereafter, despite a minor decline in 2022. This consistency in gross profit suggests stable cost management and pricing strategies within the company’s operations, even as revenue growth slowed. However, operating income and net income displayed more volatility. Operating income surged by approximately 48% from 2020 to 2021 but experienced a significant drop of about 20% in 2022, holding relatively flat in 2023 before a dramatic decline of over 70% in 2024. Similarly, net income increased by nearly 45% in 2021 compared to 2020, only to fall by more than 25% in 2022, and then sharply plunge by around 80% in 2024 relative to preceding years. These pronounced swings, especially in 2024, may reflect heightened operational challenges or one-time expenses impacting profitability, despite steady top-line growth. Overall, while TELEFLEX’s revenue and gross profit trends underscore a degree of resilience, the deteriorating operating and net income margins raise concerns about the company’s financial efficiency and long-term sustainability in a competitive medical device industry environment.
This analysis is for informational purposes only and does not constitute financial advice or recommendations for any investment decisions. Please consult with a qualified financial professional for personalized guidance.